Voyager Therapeutics (VYGR) Change in Receivables (2019 - 2026)
Voyager Therapeutics (VYGR) reported Change in Receivables of -$267000.0 for Q1 2026, down 324.37% on a YoY basis from $119000.0 in Q1 2025, and up 81.26% sequentially from -$1.4 million in Q4 2025.
Voyager Therapeutics (VYGR) Change in Receivables (2019 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 5 years of Change in Receivables data on file, last reported at -$267000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 324.37% year-over-year to -$267000.0; the trailing twelve-month figure through Mar 2026 stood at -$129000.0 (down 116.41% YoY), and the FY2025 full-year result was $257000.0, up 100.33% from the prior year.
- Change in Receivables advanced to -$267000.0 in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $25.0 million in Q1 2023 to a low of -$79.3 million in Q1 2024.
- A 4-year average of -$5.4 million and a median of $85000.0 in 2025 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables slumped 417.25% in 2024 and soared 100.15% in 2025, its largest moves.
- Tracing VYGR's Change in Receivables over 4 years: stood at $25.0 million in 2023, then sank by 157.8% to -$14.4 million in 2024, then soared by 90.14% to -$1.4 million in 2025, then soared by 81.26% to -$267000.0 in 2026.
- Business Quant data shows VYGR's Change in Receivables at -$267000.0 in Q1 2026, -$1.4 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - | -267,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -267,000.00 |
| Mar 31, 2026 | -267,000.00 |
| Dec 31, 2025 | -1.43 Mn |
| Dec 31, 2025 | -1.43 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | -14.45 Mn |
| Dec 31, 2024 | -14.45 Mn |
| Sep 30, 2024 | 14.25 Mn |
| Sep 30, 2024 | 14.25 Mn |
| Jun 30, 2024 | 865,000.00 |
| Jun 30, 2024 | 865,000.00 |
| Mar 31, 2024 | -79.31 Mn |
| Mar 31, 2024 | -79.31 Mn |
| Mar 31, 2023 | 25.00 Mn |
| Mar 31, 2023 | 25.00 Mn |